Promo !

P21 Peptide 5 mg

Le prix initial était : $130.00.Le prix actuel est : $120.00.

P21 Peptide 5 mg research-grade lyophilized peptide powder in a glass vial. P21 is a CNTF-derived peptidomimetic (Ac-DGGLAG-NH2) investigated in experimental models of neurogenesis, BDNF-related signaling, synaptic plasticity and memory-associated pathways.

 

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

 

 

Purity
High-purity research grade

 

Form
Lyophilized peptide powder

 

Content
5 mg P21 per vial

 

Packaging
Glass vial with sterile closure

 

Storage
Store lyophilized at 2–8 °C in a dry, desiccated place, protected from light.

 

Molecular formula
C30H54N6O5

 

Molecular weight
≈ 578.8 g·mol⁻¹

 

Sequence
Ac-DGGLAG-NH2 (CNTF-derived; adamantylated C-terminus)

 

CAS number
1262043-41-4

P21 Peptide 5 mg

Research Overview

P21 (also referenced as Peptide 021/P021) is a CNTF-derived peptidomimetic used as a tool compound to investigate neurotrophic and neurogenic mechanisms. In experimental systems it has been applied to probe BDNF-linked pathways, hippocampal neurogenesis and synaptic plasticity across in vitro and in vivo research models.

 

Primary Research Areas

  • Neurogenesis & BDNF signaling: Models assessing progenitor proliferation, differentiation and BDNF-associated cascades.
  • Synaptic plasticity: Studies of synaptophysin/synapsin expression and structural/functional plasticity readouts.
  • Memory-associated endpoints: Cellular and animal paradigms interrogating learning and memory pathways.
  • Peptide chemistry & delivery: Investigations of adamantylated peptide stability and permeability characteristics.
Reconstitution

Recommended solvent — Bacteriostatic water

Bacteriostatic water 10ml
Overview and Research Context
  • Proposed Function: Studied for potential neurogenesis, cognitive enhancement, and the reduction of amyloid-beta or tau pathology markers in preclinical rodent models of neurodegeneration. [1, 2]
  • Regulatory Status: Classified strictly for laboratory and scientific research use. It is not approved by regulatory agencies for human consumption, clinical treatment, or therapeutic use. [1, 2]
  • Handling & Form: Typically sold as a lyophilized (freeze-dried) powder in 5 mg quantities, requiring reconstitution with bacteriostatic water or a designated solvent for experimental applications. [1, 2]
Preclinical Administration Data (Animal Studies)
  • Injectable Doses: Rodent studies typically report experimental administration ranges between 0.1 mg/kg and 1 mg/kg of body weight via subcutaneous or intraperitoneal routes. [1]
  • Alternative Routes: Laboratory literature has investigated oral stability or direct intranasal delivery to cross the blood-brain barrier at adjusted experimental volumes. [1]
  • Human Equivalency: Established clinical safety profiles, pharmacokinetic metrics, and approved human dosing guidelines do not exist. [1]
If you are looking for specific information, let me know:
  • Are you looking for details on reconstitution math for a 5 mg vial?
  • Do you need information on the preclinical mechanisms of CNTF/BDNF mimetics?
P21 (also known as Peptide 021 or P021) is a synthetic, lipophilic neurogenic peptide derived from the ciliary neurotrophic factor (CNTF) and related to components found in Cerebrolysin. It is heavily researched for its ability to cross the blood-brain barrier, promote neurogenesis, enhance cognitive function, and offer neuroprotection. [1, 2, 3, 4]
Core Characteristics & Mechanism
  • Structure: Consists of a short active fragment of CNTF modified with an adamantane group to improve lipophilicity and brain penetration. [1]
  • Function: Stimulates the creation of new neurons (neurogenesis) and synaptic plasticity in preclinical models. [1, 2]
  • Targets: Studied primarily in relation to cognitive decline, traumatic brain injury (TBI), and neurodegenerative conditions like Alzheimer’s disease. [1, 2]
Research Status & Safety
  • Preclinical Stage: Most existing data rely on animal models and cellular assays; large-scale human clinical trials are lacking.
  • Regulatory Status: Not approved by major regulatory bodies (such as the FDA) for clinical human consumption or therapy.
  • Availability: Routinely sold online or via specialty vendors strictly labeled as “for research use only” or as experimental chemical reference material, meaning safety profiles, purity standards, and optimal dosing in humans are not formally established. [1, 2, 3, 4, 5]
If you’re looking into P021/P21, would you like to explore:
  • The preclinical study findings on memory and learning?
  • How it compares to Cerebrolysin or Semax?
  • Potential risks and limitations of unapproved peptides?

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic water 10ml.

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “P21 Peptide 5 mg”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list